Verition Fund Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $33,009 - $49,612	19,766 New	19,766 $36,000
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $240,599 - $422,872	-81,010 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.67 - $4.97 $216,296 - $402,619	81,010 New	81,010 $255,000
Q4 2017 Feb 15, 2018	SELL	$17.45 - $25.6 $182,753 - $268,108	-10,473 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $197,939 - $295,338	10,473	10,473 $263,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.